ADTX Aditxt, Inc.

ADTX financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1726711 Exchange: Nasdaq SIC: 2834 (Pharmaceutical Preparations) Latest filing: 10-Q filed May 20, 2026 Data checked: Oct 21, 2026
Showing 3 of 7 annual and 0 of 27 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$4.32M (Jun 2025)
Industry (SIC)
2834 Pharmaceutical Preparations
Incorporated
DE
Fiscal Year End
December (1231)
Phone
909-488-0844
EIN
823204328
Headquarters
RICHMOND, VA, 23219
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: ADiTx Therapeutics, Inc. (2020–2021) · Aditx Therapeutics, Inc. (2020–2021)

▼ Key Metrics (TTM)

As of Mar 31, 2026
Financials
Revenue
$14.34K
Net Income
$-53.34M
Total Assets
$13.91M
Total Equity
$-35.17M
Total Debt
-
Free Cash Flow
-
Ratios
Gross Margin
19.9%
Operating Margin
-127821.4%
Net Margin
-372062.4%
Return on Equity
151.6%
Return on Assets
-383.5%
Current Ratio
0.06x

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

In fiscal 2025, Aditxt, Inc. recorded $3.19K of revenue, net loss of $43.10M, and an operating cash outflow of $25.69M. Revenue of $3.19K sets the scale for evaluating how effectively sales translated into profit and cash during the year. Revenue was 97.6% below fiscal 2024 revenue of $133.99K, marking a top-line contraction. The company reported diluted EPS of -$1153.83, adding a shareholder-level measure to the absolute income figures considered below. A diluted share base of 37.35K links the aggregate earnings figure to diluted EPS and helps frame the per-share comparison. At period end, total assets were $16.52M, framing the scale of the company’s operating and financing commitments. The revenue-to-assets relationship was 0.0x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

Gross profit was $268.00, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. The gross-profit relationship equaled 8.4% of revenue, quantifying the portion retained before operating expenses were recognized. Operations produced a $19.57M operating loss before non-operating and tax effects. After all below-operating-line items, the company recorded a net loss of $43.10M for the fiscal year. EBITDA was negative $19.30M, showing a deficit before interest, taxes, depreciation, and amortization. The company reported a pretax loss of $42.79M, before the effect of income taxes. Relative to total assets, the net loss represented 261.0%. The net loss widened to $43.10M from $40.35M in fiscal 2024.

Liquidity and Capital Structure

At period end, the $16.52M asset base was financed through $12.56M of liabilities and $3.95M of equity. The near-term balance sheet paired $3.82M of current assets with $12.22M of current liabilities at the reporting date. Current assets covered only 0.31x of current liabilities, so current liabilities exceeded current assets at period end. The company held $3.20M in cash and equivalents, a narrower liquidity measure than total current assets. The cash balance equaled 26.2% of current liabilities, showing how much near-term coverage came from cash alone. Book equity represented 23.9% of total assets, quantifying the balance-sheet share supported by shareholder capital. Relative to total assets, liabilities measured 76.1%, complementing the separate equity-based view of the company’s capital structure. Measured against total assets, cash and equivalents represented 19.4%, a balance-sheet composition measure rather than a liquidity forecast. Total assets were 48.6% lower than fiscal 2024 assets of $32.14M, measuring the company’s own balance-sheet change. Against $1.09M of equity in fiscal 2024, the current book-equity balance moved 262.3% and ended higher. The reported cash balance changed 284.0% from $833.03K in fiscal 2024, ending higher year over year.

Cash Flow and Earnings Quality

The company reported an operating cash outflow of $25.69M, rather than cash generation from operations. The company spent $13.74K on capital expenditures while operations also absorbed cash, so both ongoing activity and investment drew on liquidity during the period. Operating cash flow and capital spending combined to leave a $25.70M cash deficit after capital spending. The free-cash-flow deficit equaled 155.6% of total assets, placing the cash shortfall against the company’s resource base. The operating cash outflow widened to $25.69M from $16.76M in fiscal 2024.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for Aditxt, Inc.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $3.20K $133.99K $645.18K
Cost of Revenue $2.93K $627.47K $756.84K
Gross Profit $268 $-493.49K $-111.66K
OPERATING EXPENSES
R&D Expense $3.19M $10.89M $7.07M
SG&A Expense $15.97M $16.29M $18.61M
Other Operating Expenses (derived) $402.00K $197.86K $269.28K
Operating Income $-19.57M $-27.86M $-26.06M
NON-OPERATING INCOME / EXPENSE
Interest Income $200.18K $1.45K $10.17K
Other Income/Expense $-23.22M $-7.16M $-6.33M
Pretax Income $-42.79M $-35.02M $-32.39M
Net Income $-43.10M $-40.35M $-32.70M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-1,153.83 $-22,147,415.22 $-27,038.26
Diluted Shares 37.36K 2.00 1.21K
EBITDA $-19.30M $-27.25M $-25.63M
Depreciation & Amortization $269.27K $613.92K $435.03K
Balance Sheet
ASSETS
Cash & Equivalents $3.20M $833.03K $97.10K
Accounts Receivable $0 $43.44K $408.33K
Inventory $5.77K $11.25K $745.50K
Other Current Assets $617.36K $3.38K $217.39K
Current Assets $3.82M $2.00M $6.91M
PP&E (Net) $880.24K $1.55M $1.90M
Intangible Assets $2.78K $6.11K $9.44K
Noncurrent Assets $12.70M $30.14M $37.67M
Total Assets $16.52M $32.14M $44.58M
LIABILITIES
Accounts Payable $7.34M $10.19M $7.52M
Other Current Liabilities $190 $158 $52.88K
Current Liabilities $12.22M $23.41M $25.89M
Noncurrent Liabilities $342.91K $450.87K $2.64M
Total Liabilities $12.56M $23.86M $28.53M
EQUITY
Common Stock $412 $130 $1.32K
Additional Paid-in Capital $214.37M $169.97M $144.00M
Retained Earnings $-209.81M $-168.09M $-127.74M
Accumulated OCI $1.25M - -
Total Equity $3.95M $1.09M $16.05M
Temporary Equity - $7.20M -
Total Liabilities & Equity $16.52M $32.14M $44.58M
SUPPLEMENTAL
Shares Outstanding 411.50K 129.68K 165.00
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-25.69M $-16.76M $-19.20M
Capital Expenditures $13.74K - $14.41K
Cash from Investing $-2.44M $-5.00M $-14.41K
Cash from Financing $30.49M $22.50M $16.55M
Free Cash Flow $-25.70M - $-19.22M
Beginning Cash (CFS) $833.03K $97.10K $2.77M
Net Change in Cash $2.37M $735.93K $-2.67M
Effect of FX on Cash - - -
Calculated Ending Cash $3.20M $833.03K $97.10K
Cash per BS $3.20M $833.03K $97.10K
Cash scope difference (CFS − BS) - - -
Cash per CFS $3.20M $833.03K $97.10K

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is Aditxt, Inc.'s annual revenue?

Aditxt, Inc. reported $14.34K in revenue for trailing twelve months (ending March 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is Aditxt, Inc. profitable?

No. Aditxt, Inc. reported $-53.34M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.